Time for a strategic research response to anal cancer

被引:10
|
作者
Grulich, Andrew E. [1 ]
Hillman, Richard [1 ,2 ]
Brotherton, Julia M. L. [3 ,4 ]
Fairley, Christopher K. [4 ,5 ]
机构
[1] Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia
[2] Univ Sydney, Ctr Infect Dis & Microbiol Sexual Hlth, Sydney, NSW 2006, Australia
[3] Victorian Cytol Serv, Melbourne, Vic 3002, Australia
[4] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic 3010, Australia
[5] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic 3010, Australia
关键词
human papillomavirus; incidence; prevalence; prevention; screening; treatment; HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; PROSTATE-CANCER; NATURAL-HISTORY; HPV INFECTION; RISK-FACTORS; WOMEN; SEX; MEN; EPIDEMIOLOGY;
D O I
10.1071/SH12116
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Anal cancer was until recently regarded as a rare cancer of little consequence. The articles in this special edition of Sexual Health clearly demonstrate that anal cancer is increasing in incidence and, in some populations, it has become an urgent public health priority. In this summary paper, we will review the data presented in this issue and elsewhere on the magnitude of the issue, the means of prevention and treatment, and suggest a way forward.
引用
收藏
页码:628 / 631
页数:4
相关论文
共 50 条
  • [1] Response to: "Anal cancer screening"
    Liszewski, Walter
    Rogers, Nicole
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (02) : 368 - 368
  • [2] Anal cytology for anal cancer screening: Is it time yet?
    Darragh, TM
    DIAGNOSTIC CYTOPATHOLOGY, 2004, 30 (06) : 371 - 374
  • [3] TIME IN STRATEGIC CHANGE RESEARCH
    Kunisch, Sven
    Bartunek, Jean M.
    Mueller, Johanna
    Huy, Quy N.
    ACADEMY OF MANAGEMENT ANNALS, 2017, 11 (02): : 1005 - 1064
  • [4] A Bibliometric Analysis of Anal Cancer Research
    Kao, Yung-Shuo
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1466 - S1468
  • [5] Future Research Directions in Anal Cancer
    Oslock, Wendelyn M.
    Chu, Daniel I.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2025, 34 (01) : 127 - 132
  • [6] Optimum time to assess complete response following radiochemotherapy in anal canal cancer patients
    Scricciolo, M.
    Mantello, G.
    Cucciarelli, F.
    Vicenzi, L.
    Fabbietti, L.
    Fenu, F.
    La Macchia, M.
    Morabito, E.
    Maggi, S.
    Cardinali, M.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S658 - S658
  • [7] THE CONCEPT OF STABLE STRATEGIC TIME PERIODS IN STRATEGIC GROUP RESEARCH
    FIEGENBAUM, A
    SUDHARSHAN, D
    THOMAS, H
    MANAGERIAL AND DECISION ECONOMICS, 1987, 8 (02) : 139 - 148
  • [8] Anal dysplasia and anal cancer in liver transplant recipients: An urgent call for action for anal cancer screening and further research
    Karita, Helen Cristina Stankiewicz
    Brickman, Cristina Elena
    Chin-Hong, Peter
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (04)
  • [9] Core outcome research measures in anal cancer
    Fish, R.
    Sebag-Montefiore, D.
    Sanders, C.
    Williamson, P.
    Renehan, A.
    COLORECTAL DISEASE, 2017, 19 (08) : 782 - 783
  • [10] Research on Anal Squamous Cell Carcinoma: Systemic Therapy Strategies for Anal Cancer
    Carr, Ryan M.
    Jin, Zhaohui
    Hubbard, Joleen
    CANCERS, 2021, 13 (09)